Fund Holdings — Sanofi

Total Portfolio Value
$260.36M
Total Bought
$18.96M
Total Sold
$3.38M
Net Transaction
+$15.58M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,926016,52438,99914.98%+22,475
MeiraGTx Holdings plc(MGTX)12,197,73712,197,737079,529100,38738.56%+20,858
Immuneering Corp02,708,559+2,708,559018,9607.28%+18,960
Novavax(NVAX)6,880,4816,880,481043,34759,65422.91%+16,307
AnaptysBio821,917821,917018,24725,1679.67%+6,921
Omada Health Inc.(OMDA)524,903524,90309,60611,6064.46%+2,000
LAVA Therapeutics N.V.1,919,4551,919,45502,5342,9941.15%+461
Q32 Bio Inc.(FIXX)244,083244,08303644830.19%+120
Eledon(ELDN)814,980814,98002,2092,1110.81%-98
IGM Biosciences1,438,9750-1,438,9751,6120—-1,612
Inozyme, Inc443,2550-443,2551,7730—-1,773
Page 1 of 1
Sanofi — 13F Holdings — Q3 2025 | TickerTrail